Hyperparathyroidism Clinical Trials

• A Randomized Study of Surgery vs No Surgery in Patients with Mild Asymptomatic Primary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00004843 - Active, not recruiting
  Hyperparathyroidism
  
• Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease
  ClinicalTrials.gov Identifier: NCT00261950 - Recruiting
  Secondary Hyperparathyroidism
  
• SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients with Secondary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00117052 - Active, not recruiting
  Secondary Hyperparathyroidism; End Stage Renal Disease
  
• Asymptomatic Primary Hyperparathyroidism: A Prospective, Randomized Trial
  ClinicalTrials.gov Identifier: NCT00522028 - Active, not recruiting
  Primary Hyperparathyroidism
  
• The Effects of Alendronate After Cure of Primary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00359385 - Recruiting
  Hyperparathyroidism
  
• Treatment of Secondary Hyperparathyroidism in the Uremic Patient
  ClinicalTrials.gov Identifier: NCT00469599 - Recruiting
  Secondary Hyperparathyroidism; Chronic Kidney Disease; Vitamin D Deficiency
  
• Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis
  ClinicalTrials.gov Identifier: NCT00446329 - Recruiting
  Secondary Hyperparathyroidism
  
• Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on Dialysis
  ClinicalTrials.gov Identifier: NCT00537979 - Recruiting
  Dialysis; Secondary Hyperparathyroidism
  
• Characterization of Hyperparathyroidism and Vitamin D Deficiency in Obesity
  ClinicalTrials.gov Identifier: NCT00288873 - Active, not recruiting
  Vitamin D Deficiency; Secondary Hyperparathyroidism; Obesity
  
• Primary Hyperparathyroidism: Non-Classical Manifestations
  ClinicalTrials.gov Identifier: NCT00432939 - Recruiting
  Primary Hyperparathyroidism
  
• Comparison of Two Methods of Parathyroidectomy for Primary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00006329 - Completed
  Hyperparathyroidism
  
• A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
  ClinicalTrials.gov Identifier: NCT00037518 - Completed
  Hyperparathyroidism; Parathyroid Neoplasms
  
• Studies of Inherited Diseases of Metabolism
  ClinicalTrials.gov Identifier: NCT00001345 - Recruiting
  Hypercalcemia; Hyperparathyroidism; Multiple Endocrine Neoplasia
  
• Comparison of Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease Stage Three and Four
  ClinicalTrials.gov Identifier: NCT00285467 - Recruiting
  Secondary Hyperparathyroidism in Chronic Kidney Disease Stage 3 and 4
  
• Studies of Elevated Parathyroid Activity
  ClinicalTrials.gov Identifier: NCT00001277 - Recruiting
  Hyperparathyroidism; Hypocalcemia; Hypoparathyroidism; Parathyroid Neoplasm
  
• Calcium and Vitamin D Malnutrition in Elderly Women
  ClinicalTrials.gov Identifier: NCT00352170 - Active, not recruiting
  Osteoporosis; Secondary Hyperparathyroidism
  
• Post Transplant Study
  ClinicalTrials.gov Identifier: NCT00395902 - Completed
  Kidney Tansplant; Secondary Hyperparathyroidism; Hyperparathyroidism
  
• ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
  ClinicalTrials.gov Identifier: NCT00379899 - Recruiting
  Chronic Kidney Disease; End Stage Renal Disease; Coronary Artery Calcification; Vascular Calcification; Calcification; Cardiovascular Disease; Chronic Renal Failure; Hyperparathyroidism; Kidney Disease; Nephrology; Secondary Hyperparathyroidism
  
• CARE-2 (Calcium Acetate [PhosLo®]/Sevelamer[Renagel®] Evaluation Study 2) for Heart Calcification in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00211939 - Active, not recruiting
  Calcinosis; Arteriosclerosis; Hyperparathyroidism, Secondary
  
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00037635 - Completed
  Secondary Hyperparathyroidism; End Stage Renal Disease
  
• A Study of an Investigational Medication for the Treatment of Secondary Hyperparathyroidism in Patients on Dialysis
  ClinicalTrials.gov Identifier: NCT00042653 - Completed
  Secondary Hyperparathyroidism; End Stage Renal Disease
  
• Study on the Effect of Parathyroidectomy on Sleep
  ClinicalTrials.gov Identifier: NCT00501215 - Recruiting
  Hyperparathyroidism
  
• Acute regulation of parathyroid hormone by dietary phosphate
  ClinicalTrials.gov Identifier: NCT00037193 - Completed
  Secondary Hyperparathyroidism
  
• Effects of Vitamin D Replacement in Patients With PHPT
  ClinicalTrials.gov Identifier: NCT00538720 - Recruiting
  Hyperparathyroidism
  
• A Study of an Investigational Medication for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients
  ClinicalTrials.gov Identifier: NCT00042432 - Completed
  Secondary Hyperparathyroidism; Chronic Renal Insufficiency
  
• A Study to Evaluate the Effects of Two Vitamin D Analogs, Zemplar® Injection and Hectorol® Injection, on Intestinal Absorption of Calcium in Patients With Stage 5 Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00257920 - Recruiting
  Stage 5 Chronic Kidney Disease (CKD); Secondary Hyperparathyroidism
  
• Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
  ClinicalTrials.gov Identifier: NCT00169806 - Recruiting
  Nephrocalcinosis; Renal Calculi; Hypercalciuria; Hyperparathyroidism; Cystinuria
  
• Effectiveness of Paricalcitol in Reducing Parathyroid Hormone Levels in X-Linked Hypophosphatemic Rickets
  ClinicalTrials.gov Identifier: NCT00417612 - Recruiting
  Hypophosphatemia, Familial; Hyperparathyroidism
  
• Initial Dosing of Paricalcitol in Secondary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00307840 - Completed
  Secondary Hyperparathyroidism
  
• E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events
  ClinicalTrials.gov Identifier: NCT00345839 - Recruiting
  Secondary Hyperparathyroidism; Chronic Kidney Disease
  
• An Open Label, Single Arm Study Using Sensipar to Improve Achievement of K/DOQI Targets in Patients With ESRD.
  ClinicalTrials.gov Identifier: NCT00431496 - Recruiting
  Anemia; Secondary Hyperparathyroidism
  
• Study of Safety and Efficacy of Doxercalciferol Patients with Chronic Kidney Disease, Stages 3 Or 4, and Secondary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00123461 - Completed
  Secondary Hyperparathyroidism; Renal Failure, Chronic; Renal Insufficiency, Chronic
  
• The Efficacy of 1,25 Dihydroxycholecalciferol on the Cardiovascular System in Patients With Renal Dysfunction
  ClinicalTrials.gov Identifier: NCT00175149 - Recruiting
  Chronic Kidney Disease; Secondary Hyperparathyroidism; Left Ventricular Hypertrophy
  
• Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
  ClinicalTrials.gov Identifier: NCT00415584 - Recruiting
  Secondary Hyperparathyroidism; Hypercalcemia
  
• The Effect of Parathyroidectomy on Renal Function, Endothelial Function, and Blood Pressure
  ClinicalTrials.gov Identifier: NCT00452049 - Recruiting
  Hyperparathyroidism; Hypertension
  
• Using X-Ray Dye to Locate Hidden Parathyroid Tumors
  ClinicalTrials.gov Identifier: NCT00001394 - Completed
  Hyperparathyroidism; Parathyroid Neoplasm
  
• Cinacalcet to Treat Familial Primary Hyperparathyroidism
  ClinicalTrials.gov Identifier: NCT00325104 - Completed
  Hypercalcemia; Familial Primary Hyperparathyroidism
  
• One Week PTHrP IV Dose Escalation Study
  ClinicalTrials.gov Identifier: NCT00580788 - Not yet recruiting
  Osteoporosis; Humoral Hypercalcemia of Malignancy; Hyperparathyroidism
  
• How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis
  ClinicalTrials.gov Identifier: NCT00528788 - Recruiting
  Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Endothelial Cells; Vitamin D
  
• ACHIEVE
  ClinicalTrials.gov Identifier: NCT00135304 - Completed
  Chronic Kidney Disease; Secondary Hyperparathyroidism
  
• Safety and Effectiveness of Zemplar Injection in decreasing iPTH levels in pediatric ESRD subjects on hemodialysis
  ClinicalTrials.gov Identifier: NCT00053547 - Completed
  Secondary Hyperparathyroidism; End Stage Renal Disease
  
• START
  ClinicalTrials.gov Identifier: NCT00132431 - Completed
  Chronic Kidney Disease; Secondary Hyperparathyroidism
  
• Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
  ClinicalTrials.gov Identifier: NCT00073710 - Completed
  Secondary Hyperparathyroidism; Chronic Kidney Disease
  
• Interaction Between Anaesthetics and Methylene Blue
  ClinicalTrials.gov Identifier: NCT00513032 - Completed
  Hyperparathyroidism
  
• Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects
  ClinicalTrials.gov Identifier: NCT00527267 - Completed
  Hyperparathyroidism
  
• Evaluation of Colecalciferol Substitution in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00397475 - Completed
  Renal Insufficiency, Chronic; Hyperparathyroidism, Secondary
  
• 7 Day Continuous Parathyroid Hormone IV Infusion
  ClinicalTrials.gov Identifier: NCT00377312 - Completed
  Osteoporosis; Bone Diseases, Endocrine; Hyperparathyroidism
  
• A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection
  ClinicalTrials.gov Identifier: NCT00463021 - Completed
  Secondary Hyperparathyroidism
  
• A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
  ClinicalTrials.gov Identifier: NCT00189501 - Completed
  Nephrology
  
• A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis
  ClinicalTrials.gov Identifier: NCT00454350 - Completed
  Secondary Hyperparathyroidism
  
• A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis
  ClinicalTrials.gov Identifier: NCT00418600 - Completed
  Secondary Hyperparathyroidism
  
• Regulation of Bone Formation in Renal Osteodystrophy
  ClinicalTrials.gov Identifier: NCT00560300 - Completed
  Secondary Hyperparathyroidism; Renal Osteodystrophy
  
• Treatment for Patients with Secondary Hyperparathyroidism of End-Stage Renal Disease (ESRD)
  ClinicalTrials.gov Identifier: NCT00110929 - Completed
  End-Stage Renal Disease
  
• Cinacalcet HCl in Chronic Kidney Disease Subjects with Secondary Hyperparathyroidism Not Receiving Dialysis
  ClinicalTrials.gov Identifier: NCT00094484 - Completed
  Kidney Diseases; Chronic Disease